Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12018016 Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors

Patent 12018016 was granted and assigned to Amgen on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

ChemoCentryx

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120180160

Patent Inventor Names

Christopher W. Lange0

Howard S. Roth0

Ju Yang0

Daniel R. Marshall0

Rebecca M. Lui0

Antoni Krasinski0

Aubrie Harland0

Penglie Zhang0

Date of Patent

June 25, 2024

Patent Application Number

178202710

Date Filed

August 17, 2022

Patent Citations

‌

US Patent 8153793 Sulfonamide derivative having PGD2 receptor antagonistic activity

‌

US Patent 9163017 Anti-viral compounds

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12018016 Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API